Galmed Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report
Apr 4 16:57 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 19 16:34 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 15 09:15 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
Feb 14 14:18 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Feb 14 09:57 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Allen Baharaff(6.2%),G. Yarom Medical Research Ltd.(4.5%)
Feb 12 16:22 ET
Galmed Pharmaceuticals | EFFECT: Others
Nov 30, 2023 00:15 ET
Galmed Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Nov 22, 2023 16:48 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 22, 2023 16:05 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 20, 2023 16:37 ET
Galmed Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Nov 1, 2023 16:15 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 26, 2023 08:51 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 22, 2023 16:15 ET
Galmed Pharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
Sep 21, 2023 07:30 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 20, 2023 16:30 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 13, 2023 16:01 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Aug 9, 2023 16:43 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 9, 2023 16:30 ET
Galmed Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Aug 2, 2023 16:30 ET
Galmed Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
Jul 21, 2023 10:12 ET
No Data
No Data